ALIGN TECHNOLOGY, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ALIGN TECHNOLOGY, INC. (ALGN) reported Cash and Cash Equivalents, Period Increase (Decrease) of $57.11 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-28
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $86.91M.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $4.43M, a 98.24% decline year-over-year.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $97.18M, a 631.35% increase year-over-year.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was -$131.41M.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $57.11M, a 74.25% decline from fiscal 2016.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $221.78M.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$32.16M.
- ALIGN TECHNOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$43.08M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $86.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $91.34M derived: sum of 2 quarters · filed 2019-02-28 | $188.52M derived: sum of 3 quarters · filed 2019-02-28 | $57.11M 10-K · filed 2019-02-28 | $60.24M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $101.61M derived: sum of 2 quarters · filed 2018-11-01 | -$29.80M 10-Q · filed 2018-11-01 | -$26.66M 10-Q · filed 2017-11-02 | -$60.25M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $97.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$34.23M 10-Q · filed 2018-08-02 | -$31.09M 10-Q · filed 2017-08-03 | -$64.68M derived: sum of 3 quarters · filed 2019-02-28 | $187.56M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | -$131.41M 10-Q · filed 2018-05-03 | -$128.25M 10-Q · filed 2017-05-04 | -$161.86M derived: sum of 2 quarters · filed 2019-02-28 | $90.38M derived: sum of 3 quarters · filed 2019-02-28 | $103.67M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$30.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $221.79M derived: sum of 2 quarters · filed 2019-02-28 | $235.08M derived: sum of 3 quarters · filed 2019-02-28 | $221.78M 10-K · filed 2019-02-28 | $221.56M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $252.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $265.53M derived: sum of 2 quarters · filed 2017-11-02 | $252.23M 10-Q · filed 2017-11-02 | $245.91M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $13.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$8.00K 10-Q · filed 2017-08-03 | -$6.33M derived: sum of 3 quarters · filed 2018-02-28 | $5.95M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | -$13.30M 10-Q · filed 2017-05-04 | -$19.62M derived: sum of 2 quarters · filed 2018-02-28 | -$7.33M derived: sum of 3 quarters · filed 2018-02-28 | -$35.56M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $5.96M derived: sum of 2 quarters · filed 2018-02-28 | -$22.26M derived: sum of 3 quarters · filed 2018-02-28 | -$32.16M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $12.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$15.94M derived: sum of 2 quarters · filed 2016-11-08 | -$25.83M 10-Q · filed 2016-11-08 | -$6.64M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | -$28.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$38.12M 10-Q · filed 2016-08-04 | -$18.92M derived: sum of 3 quarters · filed 2017-02-28 | -$5.72M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | -$9.89M 10-Q · filed 2016-05-05 | $9.30M derived: sum of 2 quarters · filed 2017-02-28 | $22.51M derived: sum of 3 quarters · filed 2017-02-28 | $7.21M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $19.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $32.40M derived: sum of 2 quarters · filed 2017-02-28 | $17.11M derived: sum of 3 quarters · filed 2017-02-28 | -$43.08M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $13.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$2.09M derived: sum of 2 quarters · filed 2015-10-29 | -$62.28M 10-Q · filed 2015-10-29 | $4.84M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$15.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$75.48M 10-Q · filed 2015-07-30 | -$8.37M derived: sum of 3 quarters · filed 2016-02-25 | $2.97M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$60.19M 10-Q · filed 2015-05-01 | $6.93M derived: sum of 2 quarters · filed 2016-02-25 | $18.27M derived: sum of 3 quarters · filed 2016-02-25 | -$145.98M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $67.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $78.46M derived: sum of 2 quarters · filed 2016-02-25 | -$85.79M derived: sum of 3 quarters · filed 2016-02-25 | -$63.43M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $11.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$152.91M derived: sum of 2 quarters · filed 2014-10-30 | -$130.55M 10-Q · filed 2014-10-30 | -$129.07M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | -$164.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$141.89M 10-Q · filed 2014-07-31 | -$140.41M derived: sum of 3 quarters · filed 2015-02-26 | -$98.30M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $22.36M 10-Q · filed 2014-05-01 | $23.84M derived: sum of 2 quarters · filed 2015-02-26 | $65.95M derived: sum of 3 quarters · filed 2015-02-26 | $104.38M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $43.59M derived: sum of 2 quarters · filed 2015-02-26 | $82.03M derived: sum of 3 quarters · filed 2015-02-26 | $65.71M 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $42.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $80.55M derived: sum of 2 quarters · filed 2013-11-01 | $64.23M 10-Q · filed 2013-11-01 | |||||
| 2012-06-30 | $38.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $22.12M 10-Q · filed 2013-08-02 | ||||||
| 2012-03-31 | -$16.31M 10-Q · filed 2013-05-03 | |||||||
| 2012-03-30 | -$16.31M 10-Q · filed 2013-05-03 | $22.13M derived: sum of 2 quarters · filed 2014-02-28 | $55.75M derived: sum of 3 quarters · filed 2014-02-28 | -$84.25M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $38.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $72.07M derived: sum of 2 quarters · filed 2014-02-28 | -$67.93M derived: sum of 3 quarters · filed 2014-02-28 | -$53.99M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $33.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$106.38M derived: sum of 2 quarters · filed 2012-11-09 | -$92.44M 10-Q · filed 2012-11-09 | -$62.70M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | -$140.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | -$126.06M 10-Q · filed 2012-11-09 | -$96.32M derived: sum of 3 quarters · filed 2013-03-01 | -$67.19M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $13.94M 10-Q · filed 2012-11-09 | $43.68M derived: sum of 2 quarters · filed 2013-03-01 | $72.81M derived: sum of 3 quarters · filed 2013-03-01 | $118.20M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $29.74M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $58.86M derived: sum of 2 quarters · filed 2013-03-01 | $104.26M derived: sum of 3 quarters · filed 2013-03-01 | $128.18M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $29.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $74.52M derived: sum of 2 quarters · filed 2011-11-04 | $98.44M 10-Q · filed 2011-11-04 | $128.96M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $45.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $69.31M 10-Q · filed 2011-08-08 | $99.84M derived: sum of 3 quarters · filed 2012-02-29 | $113.62M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $23.92M 10-Q · filed 2011-05-05 | $54.45M derived: sum of 2 quarters · filed 2012-02-29 | $68.22M derived: sum of 3 quarters · filed 2012-02-29 | |||||
| 2009-12-31 | $30.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $44.30M derived: sum of 2 quarters · filed 2012-02-29 | $79.39M 10-K · filed 2012-02-29 | |||||
| 2009-09-30 | $13.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $48.86M 10-Q · filed 2010-11-04 | ||||||
| 2009-06-30 | $35.08M 10-Q · filed 2010-08-05 | |||||||
| 2008-12-31 | -$2.02M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |